Skip to main content

Table 3 IL28B genotype expression in non-diabetic and diabetic groups according to grades of fibrosis

From: Impact of IL-28B gene polymorphism on chronic hepatitis-C patients progression with diabetes and non-diabetes

Variable CC CT TT χ2 P
G1 a and b non-diabetic
(n = 80)
Fibrosis
(n = 40)
18 (45.0%) 15
(37.5%)
7
(17.5%)
2.65 0.27*
Cirrhosis
(n = 40)
11 (27.5%) 20
(50%)
9
(22.5%)
OR(95%CI) 1 2.18
(0.71–6.78)
2.1
(0.52–8.79)
GII a and b diabetic
(n = 80)
Fibrosis
(n = 40)
6 (15.0%) 26
(65.0%)
8
(20.0%)
2.26 0.32*
Cirrhosis
(n = 40)
5 (12.5%) 21
(52.5%)
14
(35.0%)
OR(95%CI) 1 0.97
(0.22–4.36)
2.1
(0.39–11.87)
  1. X2 = Chi-square test *: nonsignificant = p > 0.05